Do not give cancer a chance - Onkocheck (GEKKO)

Recruiting

• Conditions: C18; C34; C16; C50; C25; C19; Malignant neoplasm of colon; Malignant neoplasm of bronchus and lung; Malignant neoplasm of stomach; Malignant neoplasm of breast

• Registration Number: DRKS00010931
• Lead Sponsor: ationales Centrum für Tumorerkrankungen (NCT) und Deutsches Krebsforschungszentrum (DKFZ)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-10-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20000

Inclusion Criteria

For the participants of arm A the following inclusion and exclusion criteria apply.
Inclusion Criteria:
• Women or men
• Age 30 years or older
• Appointment for a screening/diagnostic colonoscopy at a NCT Collaborative Practice
• Willingness to schedule a separate outpatient visit at the NCT or participate in the study recruitment at the NCT Collaborative Practice or Clinic
• Ability to speak and understand German
• Provision of written informed consent

For the patients of arm B the following inclusion and exclusion criteria apply.

• Newly diagnosed gastrointestinal cancer (including also GIST and Insulinoma),
• Other gastrointestinal diseases for which differential diagnosis with gastrointestinal cancers is relevant , such as acute and chronic pancreatitis (AP, CP),
• Intraductal mucinous neoplasm of the pancreas (IPMN),
• Space requirements in the digestive tract
• Suspicion of” (any of the in the inclusion criteria mentioned diseases) diagnosis
• Selected newly diagnosed other cancers such as lung or breast cancer
• Women or men
• Age 25 years or older for breast cancer patients
• Age 30 or older for all other cancer patients
• Ability to speak and understand German
• Provision of written informed consent

Exclusion Criteria

Arm A:

• Not able to understand and sign the informed consent form in person
• Previous diagnosis of colorectal cancer
• Known diagnosis of Lynch syndrome or Familial Adenomatous Polyposis
• Known diagnosis of inflammatory bowel disease (Crohn’s disease, ulcerative colitis)
• Preceding colonoscopy within the past 5 years

Arm B:

• Inflammatory bowel disease such as crohn's disease and ulcerative colitis
• Not able to understand and sign the informed consent form in person
• Recurrent tumor disease

Study & Design

• Study Type: observational
• Study Design: Not specified